Novartis sues Amgen over migraine treatment Aimovig

Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotech of trying to back out of the companies' agreements to develop and market Aimovig for the prevention of migraines.

from Reuters: Health News https://ift.tt/2Uu5QOj
via IFTTT